Tanju Kapagan

15PUBLICATIONS
37CO-AUTHORS
PharmacogenomicsCancer geneticsPredictive and prognostic markersClinical midwiferyRadiation therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Jul 01, 2026
Polypharmacy and clinical outcomes in geriatric patients with metastatic hormone-sensitive prostate cancer treated with androgen receptor pathway inhibitors.

|May 13, 2026
Prevalence of Malnutrition, Frailty, and Cachexia Across Different Cancer Subtypes: Distribution by Age (<65 and ≥65).

|Apr 23, 2026
Predictive Role of Serum Inflammatory Markers in Metastatic Luminal A/B Breast Cancers Receiving CDK-4/6 Inhibitors Therapy.

|Apr 14, 2026
Prognostic Impact of the Lung Immune Prognostic Index in Metastatic Non-Small Cell Lung Cancer Patients Treated with Nivolumab.

Şahin Bedir, Tanju Kapağan, Yakup Bozkaya

|Mar 14, 2026
Impact of HER2-Low Expression on Clinical Outcomes in Metastatic Breast Cancer Treated with CDK4/6 Inhibitors.

Şahin Bedir, Tanju Kapagan, Burçin Çakan Demirel

|Nov 03, 2025
Association between metabolic status and nivolumab efficacy in metastatic non-small cell lung cancer: Focus on resting energy expenditure.

Tanju Kapagan, Nilufer Bulut, Gokmen Umut Erdem

Pageof 3

Frequent Collaborators

8 joint publications

Nilufer Bulut

7 joint publications

Gokmen Umut Erdem

2 joint publications

Ece Yontan

2 joint publications

Beyza Canan Ozkan Kardes